Anticancer Agents Med Chem 2020 Jan 23
Betulinic Acid and Brosimine B Hybrid Derivatives as Potential Agents against Female Cancers.
Garcês de Couto NM, Willig JB, Ruaro TC, de Oliveira DL, Buffon A, Pilger DA, Arruda MSP, Miron D, Zimmer AR, Gnoatto SCB
Cancer is a multifactorial disease, representing one of the leading causes of death worldwide. On a global estimate, breast cancer is the most frequen ...
Read More
Source: PubMed
Semin. Cancer Biol. 2020 Jan 18
Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force.
Wang Z, Zhi K, Ding Z, Sun Y, Li S, Li M, Pu K, Zou J
Cancer has thwarted as a major health problem affecting the global population. With an alarming increase in the patient population suffering from dive ...
Read More
Source: PubMed
RNA Biol 2020 Jan 19
Pan-cancer analysis of RNA methyltransferases identifies FTSJ3 as a potential regulator of breast cancer progression.
Manning M, Jiang Y, Wang R, Liu L, Rode S, Bonahoom M, Kim S, Yang ZQ
RNA methylation, catalysed by a set of RNA methyltransferases (RNMTs), modulates RNA structures, properties, and biological functions. RNMTs are incre ...
Read More
Source: PubMed
Conf Proc IEEE Eng Med Biol Soc
Creating Visual Vocabularies for The Retrieval And Classification of Histopathology Images.
Kallipolitis A, Maglogiannis I
State-of-the-art technologies in the fields of computer vision and machine learning led the automatic recognition of malignant structures in histopath ...
Read More
Source: PubMed
Methods Mol. Biol.
Microscopic Methods for Analysis of Macrophage-Induced Tunneling Nanotubes.
Carter KP, Segall JE, Cox D
Macrophages are known to play multiple roles in the breast cancer microenvironment including the promotion of tumor cell invasion that is dependent on ...
Read More
Source: PubMed
